Peptide therapy TikTok claims: what the science actually supports

What's this video probably claiming?

Without a transcript, we're working from context clues, but peptide TikTok follows predictable patterns. Creators in this space typically position peptides like BPC-157, TB-500, CJC-1295, ipamorelin, and GHK-Cu as near-miraculous compounds for accelerating injury recovery, stimulating growth hormone, improving sleep, and slowing aging. MK-677, which is not technically a peptide but a ghrelin mimetic, frequently gets bundled into these conversations as a "safe" alternative to anabolic steroids. Semax and selank get pitched as nootropics that sharpen cognition and reduce anxiety without the downsides of pharmaceuticals. The framing is almost always optimistic: these are compounds the medical establishment supposedly ignores, available to biohackers willing to do their own research. What you rarely hear is an honest accounting of which claims have actual human trial data behind them and which are extrapolated from rodent studies at doses nobody has validated in humans.

What does the science actually show?

The honest answer is: it depends enormously on the specific peptide and the specific claim. BPC-157 has shown genuine regenerative effects in animal models, including accelerated tendon healing in rats (Pevec et al., 2010, Journal of Orthopaedic Research), but zero randomized controlled trials in humans exist as of 2024. TB-500, a synthetic fragment of thymosin beta-4, has similarly promising preclinical data for cardiac and musculoskeletal repair but no published human efficacy trials. CJC-1295 combined with ipamorelin does demonstrably raise IGF-1 and growth hormone pulse amplitude in humans. Ionescu and colleagues (2008, Journal of Clinical Endocrinology and Metabolism) showed CJC-1295 increased IGF-1 levels by 28-39% over 28 days in healthy adults. GHK-Cu has legitimate published data on wound healing and collagen synthesis in vitro and in small human skin studies. MK-677 has actual human trial data showing increased GH and IGF-1 but also clinically significant increases in fasting glucose and insulin resistance (Nass et al., 2008, Annals of Internal Medicine).

Where does the social media noise diverge from clinical reality?

The gap between TikTok peptide content and clinical reality is wide enough to matter. First, most peptides discussed in these videos are administered by injection, a detail that gets glossed over in favor of showing a vial and a confident voiceover. Oral bioavailability for most peptides is essentially zero due to gastrointestinal degradation. Second, sourcing matters enormously. Peptides sold as "research chemicals" online have no quality oversight, and independent testing has found significant dosing inaccuracies and contamination in grey-market products (Rahnema et al., 2015, Fertility and Sterility, in the context of SARMs and peptide compounds). Third, stacking multiple peptides, which these videos frequently encourage implicitly, has essentially no human safety data. The interaction between a GHRH analog like CJC-1295 and a compound like MK-677 affecting both ghrelin and IGF-1 pathways simultaneously has not been studied in any controlled human trial. Presenting this as routine optimization rather than experimental self-experimentation is a meaningful misrepresentation of actual risk.

What should you actually know?

A few things are worth holding onto here. Some peptides do have a legitimate place in supervised clinical practice, particularly growth hormone secretagogues for documented GH deficiency and certain wound-healing peptides in specific dermatological applications. The problem is not that these compounds are inherently dangerous or fraudulent. The problem is the confidence with which unverified claims circulate, disconnected from the actual evidence base. MK-677, for example, is frequently promoted for muscle gain and fat loss, but Nass et al. found it significantly worsened insulin sensitivity in older adults over 12 months, a side effect that gets almost no airtime on TikTok. GHK-Cu has reasonable topical data but injectable claims exceed what the published literature supports. If you are genuinely interested in peptide therapy, the conversation belongs with a licensed provider who can order baseline labs, confirm you are an appropriate candidate, and monitor outcomes. That is not gatekeeping. That is what responsible use of experimental compounds actually looks like.